ARK Genomic Revolution ETF $ARKG Shares Sold by Financial Perspectives Inc

Financial Perspectives Inc lessened its position in ARK Genomic Revolution ETF (BATS:ARKG) by 41.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,657 shares of the company’s stock after selling 1,894 shares during the period. Financial Perspectives Inc’s holdings in ARK Genomic Revolution ETF were worth $65,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. LPL Financial LLC increased its holdings in shares of ARK Genomic Revolution ETF by 13.4% in the 1st quarter. LPL Financial LLC now owns 783,702 shares of the company’s stock worth $16,270,000 after acquiring an additional 92,444 shares during the period. Clearwater Capital Advisors LLC increased its holdings in shares of ARK Genomic Revolution ETF by 24.0% in the 1st quarter. Clearwater Capital Advisors LLC now owns 195,875 shares of the company’s stock worth $4,066,000 after acquiring an additional 37,970 shares during the period. Prudential PLC increased its holdings in shares of ARK Genomic Revolution ETF by 13.3% in the 1st quarter. Prudential PLC now owns 181,670 shares of the company’s stock worth $3,771,000 after acquiring an additional 21,300 shares during the period. Kingstone Capital Partners Texas LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the 2nd quarter worth about $3,844,000. Finally, Raymond James Financial Inc. increased its holdings in shares of ARK Genomic Revolution ETF by 65.4% in the 1st quarter. Raymond James Financial Inc. now owns 142,362 shares of the company’s stock worth $2,955,000 after acquiring an additional 56,283 shares during the period.

ARK Genomic Revolution ETF Trading Up 31.3%

Shares of ARKG opened at $31.01 on Monday. The firm has a 50-day moving average price of $26.93 and a 200 day moving average price of $24.21. ARK Genomic Revolution ETF has a 52-week low of $17.51 and a 52-week high of $31.16.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.